Compared with that in the tumor masses treated with normal saline and other treatments, the decrease of CD31-immunolabeled cells in the tumor masses treated with anlotinib combined with chemoradiotherapy and anlotinib combined with radiotherapy was significant (P < 0.05) (Figures 9, 10). Here, PECAM1 is linked to neoplasm.